Last updated: 2026-09-14 21:19:00. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
HeartSciences Inc. (HSCS) operates in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector and is listed on NASDAQ. The stock is currently priced at $3.55, with a market capitalization of $15.28M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.63 to $4.35. This page covers its latest market performance, valuation, price trends and company information.
$15.28M | |
$3.39 | |
$600.00 | |
$1.63 | |
$3.39 | |
75.91K | |
2.31M | |
-- | |
$4.35 | |
$1.63 | |
-- | |
-- |
HeartSciences Inc. (HSCS) is trading at $3.49 in after-hours trading as of 2026-09-14 20:32:00, up 2.98% ($0.10) from the regular-session close of $3.39.
After-hours trading shows how investors are pricing HSCS after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, HeartSciences Inc. (HSCS) moved from $3.01 to $3.55, representing a gain of 17.94% ($0.54).
The stock traded between $2.96 and $4.35 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 161.49 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 70.6%
HSCS is currently trading at $3.55, placing it 70.6% of the way from its 52-week low of $1.63 to its 52-week high of $4.35. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.
| Industry | ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES |
| Employees | 14 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of HeartSciences Inc. (HSCS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.